MedTrace Logo

Prospective Prostate Cancer and Patient-reported Outcomes Registry

NCT04694924 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 5000

Last updated 2024-05-22

No results posted yet for this study

Summary

This study aims to evaluate the use of a digital solution, integrated into the electronic health record, for prospective and structured reporting of clinical and patient-reported outcomes for patients diagnosed with localized or locally advanced prostate cancer.

Conditions

  • Prostate Cancer
  • Adenocarcinoma of the Prostate
  • Locally Advanced Prostate Carcinoma
  • Locally Advanced Prostate Adenocarcinoma

Interventions

OTHER

standard of care

No other procedures than those performed during the usual care for prostate cancer patients will be done. No study medication will be provided as part of participation. Clinical outcomes will be reported via predefined electronic forms, integrated into the electronic health record (EHR). Patient-reported outcomes will be collected electronically. All treatment decisions will be made at the discretion of the investigator or treating physician.

Sponsors & Collaborators

  • AZ Sint-Jan AV

    collaborator OTHER

  • General Hospital Groeninge

    collaborator OTHER

  • AZ Sint-Blasius Dendermonde

    collaborator UNKNOWN

  • Universitaire Ziekenhuizen KU Leuven

    lead OTHER

Principal Investigators

  • Wouter Everaerts, MD, PhD · UZ Leuven / KU Leuven

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-01
Primary Completion
2030-10-31
Completion
2030-10-31

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04694924 on ClinicalTrials.gov